Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ABAbbott Laboratories logo

Abbott Laboratories (ABT)

New York Stock Exchange · Currency in USD
$103.70 ▲ +1.19 (+1.16%)
At close: Oct 23, 4:01 PM ET. Market closed.
$103.50 ▼ -0.20 (-0.19%)
After hours: Oct 23, 7:43 PM ET

Summary

Previous Close
$102.51
Open
$102.28
Day's Range
$101.56 – $104.00
52 Week Range
$81.97 – $132.03
Volume
10,296,342
Avg. Volume
10,574,326
Market Cap
$179.44B
Beta (5Y Monthly)
0.58
PE Ratio (TTM)
38.41
EPS (TTM)
$2.70
Earnings Date
Jan 28, 2027
Forward Dividend & Yield
$2.52 (2.43%)
Ex-Dividend Date
Oct 15, 2026
1y Target Est
$121.36

Profile: Abbott Laboratories

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
115,000
CEO
Robert Ford
Website
abbott.com

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine.

Earnings

Next report: Thu, Jan 28, 2027
EPS estimate $1.64 · Revenue est. $13.23B
DateEst.Actual
Oct 21, 2026$1.42$1.42Beat
Jul 16, 2026$1.28$1.31Beat
Apr 16, 2026$1.14$1.15Beat
Jan 22, 2026$1.50$1.50Beat
Oct 15, 2025$1.30$1.30Beat
Jul 17, 2025$1.26$1.26Beat

Analyst view

Consensus price target
$121.36 ▲ +17.0%
Range $112.00 – $130.00
Rating: Buy
Buy 79% · Hold 21% · Sell 0%

Get free alerts on ABT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.